AMRC vs EME Stock Comparison
Compare AMRC and EME across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between AMRC and EME?
EME leads the current stock comparison as EMCOR Group, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Ameresco, Inc. vs EMCOR Group, Inc.
EME leads
EME leads by 23 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 30 points over 30 sessions. Wall Street currently favors AMRC on target upside.
Competitive: 5 of 6 evidence groups support EME, its lead is narrowing, and its current signal state is conflicted.
Ameresco, Inc.
EMCOR Group, Inc.
The Algovestiq AIQ Score currently favors EME over AMRC, 53 versus 30 as of Sep 6, 2026. EME's advantage is driven primarily by stronger quality and risk resilience, while AMRC holds the stronger momentum profile. EME also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AMRC. 5 of 6 covered evidence groups favor EME today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. EME lead: Weakening — the AIQ differential moved from 30 to 23 points over 30 sessions.
Compare Ameresco, Inc. and EMCOR Group, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare AMRC and EME against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality30%17 vs 77EME +60
- Risk Resilience15%25 vs 69EME +44
- Momentum25%25 vs 9AMRC +16
- Value30%50 vs 59EME +9
5 of 6 evidence groups favor EME. EME’s edge is concentrated in quality and risk resilience; AMRC keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-09-05, compared against the prior scored session 2026-09-04.
No factor moved materially.
No new signals fired.
No factor moved materially.
No new signals fired.
EME's lead was unchanged in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — AMRC and EME both carry a full feed there.
The central trade-off
EME (EMCOR Group, Inc.): the stronger current systematic profile, led by quality and risk resilience.
AMRC (Ameresco, Inc.): the counter-case, on momentum, analyst expectations — but at materially higher volatility, 75.7% against 35.5%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
EMEEME on the overall AIQ Score, which weights Quality and Value at 30% each.
Growth
AMRCAMRC on combined revenue and EPS growth.
Value
EMEEME on the peer-relative Value factor, by 9 points.
Momentum
AMRCAMRC on the Momentum factor, by 16 points.
Lower downside
EMEEME on Risk Resilience, by 44 points.
Analyst upside
AMRCAMRC on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors EME, analyst targets favor AMRC. That disagreement is the most useful thing on this page.
| Measure | AMRC | EME | Note |
|---|---|---|---|
| Implied upside to target | +87.5% | +37.9% | AMRC has more room |
| Target dispersion | +59.9% | +28.8% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 4 | 5 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor EME. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | EME | 30 vs 53 |
| Fundamentals | EMEon balance | revenue growth 28.4% vs 11.4%; EPS growth 151.4% vs 30.8%; TTM ROE 2.5% vs 38.4%; gross margin 16.1% vs 19.7%; operating margin 7% vs 10.2% — EME takes 3 of 5 decided legs, not all of them |
| Valuation | EME | Value 50 vs 59 |
| Technicals | EME | Price vs 50-day -3.9% vs -3.2%; vs 200-day -18.7% vs -0.7% |
| Risk Resilience | EME | Risk Resilience 25 vs 69 |
| Analyst expectations | AMRC | Target upside 87.5% vs 37.9% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AMRC and EME and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 23 points. (supports the conclusion holding)
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on EME.
How the comparison changed
120 daily snapshots · Apr 24 – Sep 5EME lead: Weakening — the AIQ differential moved from 30 to 23 points over 30 sessions.
- Today
- EME +23
- 30 vs 53
- 7 sessions ago
- EME +23
- 30 vs 53
- 30 sessions ago
- EME +30
- 42 vs 72
- 90 sessions ago
- EME +26
- 30 vs 56
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 4 bearish / 1 neutral, conflicted
- Death Cross Active — bearish, trend, long horizon (18.17%)
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
- Beta Spike Warning — bearish, risk, long horizon
2 bullish / 1 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (2.64%)
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
EME leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.67%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.73%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AMRC closes the Quality gap — currently 60 points behind, the largest single contributor to EME's edge.
- 2AMRC's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3EME's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4The narrowing continues — the lead has already given back 7 points over 30 sessions, and a further 23-point move would eliminate EME's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
EME leads on balance| Metric | AMRC | EME |
|---|---|---|
| Revenue growth (YoY) | 28.4% | 11.4% |
| EPS growth (YoY) | 151.4% | 30.8% |
| Gross margin | 16.1% | 19.7% |
| Operating margin | 7% | 10.2% |
| Return on equity (TTM) | 2.5% | 38.4% |
| Debt to equity | 1.5 | 0 |
Performance
EME leads 5 of 6 windows| Metric | AMRC | EME |
|---|---|---|
| 1 week (5 sessions) | 5.3% | 1.9% |
| 1 month (20 sessions) | -9.7% | -7.7% |
| 3 months (63 sessions) | -18.7% | -7.7% |
| 6 months (126 sessions) | -9.9% | 6.9% |
| Year to date | -21% | 23.3% |
| 1 year (252 sessions) | -9.7% | 20.2% |
Technicals
EME has the stronger structure| Metric | AMRC | EME |
|---|---|---|
| RSI (14) | 29.6 | 25.4 |
| ADX (14) | 15.9 | 24 |
| Price vs 50-day | -3.9% | -3.2% |
| Price vs 200-day | -18.7% | -0.7% |
| Volatility (1M, annualized) | 75.7% | 35.5% |
Risk
EME is the more resilient| Metric | AMRC | EME |
|---|---|---|
| Beta | 2.95 | 1.92 |
| Sharpe ratio | 0.13 | 0.5 |
| Sortino ratio | 0.23 | 0.68 |
| Max drawdown | -57.2% | -28.7% |
| Current drawdown | -46.5% | -20.1% |
| Annualized volatility | 71.9% | 45% |
| Value at risk (95%) | -6.5% | -3.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AMRC or EME?
On the Algovestiq AIQ Score, EME is the stronger of the two as of Sep 6, 2026, scoring 53 against AMRC's 30. The edge comes from quality and risk resilience. AMRC is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AMRC or EME the better buy right now?
EME carries the stronger systematic profile as of Sep 6, 2026, and the comparison is rated Competitive — 5 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor EME over AMRC?
The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. EME leads Quality by 60 points; EME leads Risk Resilience by 44 points; AMRC leads Momentum by 16 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AMRC or EME?
Analyst price targets imply +87.5% upside for AMRC and +37.9% for EME, so the Street currently favors AMRC. That points the opposite way to the AIQ Score, which favors EME. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AMRC or EME?
EME is the better-valued of the two on the peer-relative Value factor. EME on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AMRC or EME?
AMRC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AMRC or EME?
AMRC on the Momentum factor, by 16 points. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AMRC or EME?
EME is the more resilient of the two, so the other name carries the higher downside risk. EME on Risk Resilience, by 44 points. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AMRC more profitable than EME?
EME leads on the comparable margin measures — gross margin 16.1% vs 19.7%; operating margin 7% vs 10.2%; ttm roe 2.5% vs 38.4%.
Is EME's lead over AMRC getting stronger or weaker?
EME lead: Weakening — the AIQ differential moved from 30 to 23 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-04-24 and 2026-09-05. The lead has not changed hands in that window.
What would change the AMRC vs EME verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AMRC closes the Quality gap — currently 60 points behind, the largest single contributor to EME's edge; AMRC's Death Cross Active resolves — a bearish trend rule currently active against it; EME's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 7 points over 30 sessions, and a further 23-point move would eliminate EME's advantage entirely.
What do the current signals say about AMRC and EME?
AMRC: 1 bullish / 4 bearish / 1 neutral, conflicted. EME: 2 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AMRC is Death Cross Active (bearish, long horizon). On EME it is Golden Cross Active (bullish, long horizon).
Compare AMRC and EME with others
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.